FDA Approves COLISTIMETHATE SODIUM — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has been granted FDA approval for the INTRAMUSCULAR formulation of Colistimethate Sodium (brand and generic). The authorization allows the company to enter a fragment of the market previously served exclusively by inhaled products, potentially capturing a share of the patient population requiring non-inhaled therapies for cystic fibrosis.